Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Resources Medical Holdings Co ( (HK:1515) ) has shared an update.
China Resources Medical Holdings Co has entered into a new Cooperation Framework Agreement with CR Pharmaceutical Group for the period of 2026 to 2028. This agreement aims to continue the provision of supply chain management services, improving efficiency and reducing costs for CR Pharmaceutical Group’s medical supplies. The transactions under this agreement are classified as continuing connected transactions under the Listing Rules, requiring reporting and annual review but exempt from certain approval requirements.
The most recent analyst rating on (HK:1515) stock is a Sell with a HK$3.00 price target. To see the full list of analyst forecasts on China Resources Medical Holdings Co stock, see the HK:1515 Stock Forecast page.
More about China Resources Medical Holdings Co
China Resources Medical Holdings Co is involved in the healthcare industry, providing supply chain management services for medical supplies. The company focuses on enhancing the efficiency of supply chain operations and reducing costs for its clients, particularly within the medical sector.
Average Trading Volume: 6,236,962
Current Market Cap: HK$4.17B
For detailed information about 1515 stock, go to TipRanks’ Stock Analysis page.